The global ELISpot and Fluorospot assay market was valued at USD 311.8 million in 2024 and is projected to reach USD 450.0 million by 2030, expanding at a CAGR of 6.3% from 2025 to 2030. This steady growth is driven by the increasing prevalence of chronic and infectious diseases, the expansion of drug discovery initiatives, and the rising utilization of these assays in both...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek